| Name | Astegolimab |
|---|
| Description | Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research[1]. |
|---|---|
| Related Catalog | |
| Target |
ST2 |
| References |
| No Any Chemical & Physical Properties |